ConductScience.org, home

Paper523360

In vitro synergy and antagonism of antifungal agents against yeast-like fungi.

Dupont B and 1 other. Postgrad Med J, 1979. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. In vitro synergy and antagonism of antifungal agents against yeast-like fungi. Papers, record 523360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/523360

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro synergy and antagonism of antifungal agents against yeast-like fungi.
PubMed
Journal
Postgrad Med J
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dupont BB
2Drouhet EE

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
YeastsMajor topic
Drug Evaluation, Preclinical
Drug Synergism

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1921134[First medical cure of Candida endocarditis on a valve prosthesis].Ann Med Interne (Paris)1977https://conductscience.org/library/papers/921134PubMed
259892Letter: Antagonism between miconazole and amphotericin B.Lancet1976https://conductscience.org/library/papers/59892PubMed
31101814In vitro studies with combinations of 5-fluorocytosine and amphotericin B.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1101814PubMed
45118468Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.Proc Soc Exp Biol Med1971https://conductscience.org/library/papers/5118468PubMed

Download CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41474803In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/41474803PubMed
41040159In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis.bioRxiv2025https://conductscience.org/library/papers/41040159PubMed
38960917Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens.Curr Microbiol2024https://conductscience.org/library/papers/38960917PubMed
26048362Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.Virulence2015https://conductscience.org/library/papers/26048362PubMed
16033288Antifungal combination therapy: clinical potential.Drugs2005https://conductscience.org/library/papers/16033288PubMed
14982754Combination antifungal therapy.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14982754PubMed
8457977Compounds active against cell walls of medically important fungi.Clin Microbiol Rev1993https://conductscience.org/library/papers/8457977PubMed
7486918Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7486918PubMed
7363014Treating fungal infections.Br Med J1980https://conductscience.org/library/papers/7363014PubMed
6299182Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6299182PubMed
6295266Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295266PubMed
6280603Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6280603PubMed
3596813Problems in antifungal chemotherapy.Infection1987https://conductscience.org/library/papers/3596813PubMed
3551831Entry of ketoconazole into Candida albicans.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3551831PubMed
2665643Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2665643PubMed
2546489Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2546489PubMed
1416829Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1416829PubMed
392478Fungal endocarditis: patients at risk and their treatment.Postgrad Med J1979https://conductscience.org/library/papers/392478PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/523360

GET https://conductscience.org/api/papers/v1/523360/authors